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ABSTRACT 
Synovial sarcomas are highly aggressive soft tissue tumour with a poor and dismal 
prognosis. These tumours have a high propensity for distant metastasis and local 
recurrence.  Although originally believed to arise from synovium, these tumours have 
been found to occur anywhere in body1,2. We report here, a case of median nerve 
sarcoma in a 15-year female. This is a rare tumour, which is diagnosed only after 
histopathological examination with only a few cases reported in the literature (Table 
1). Although preoperatively tumour was thought to be a nerve sheath tumour, on 
histopathology analysis was found to be synovial sarcoma. Despite aggressive 
behaviour, wide local excision is recommended even in smaller lesions. So, the 
diagnosis should always be kept in differentials of nerve sheath tumour, as what may 
be a synovial sarcoma. 
 
 
 
INTRODUCTION 
Synovial sarcomas may arise from different and unusual sites with 
distinctive morphological genetic features3. They are mostly seen in 
extremities in young adolescents with male preponderence4. It has 
been found in unusual locations in heart, lung, small intestine, soft 
palate and peripheral nerves. Only a few cases have been reported in 
peripheral nerve. Prognosis is poor despite radical surgery, radiation 
and chemotherapy with 50-60 % survival5. 
These sarcomas have origin in synovium because of periarticular 
location, but less than 5% are continuous with synovium4. Sarcomas 
have their origin from primitive mesenchymal undifferentiated cells6. 
Synovial sarcoma is diagnosed on immunohistochemical basis because 
most of them present as lump or swelling with no clinical or diagnostic 
features7. Translocation (X;18) is diagnostic in 90% of cases8.Case 
presented here is a rare sarcoma arising from median nerve in upper 
arm. We have described here clinical, radiological features and its 
management. 
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CASE PRESENTATION 
A 15-year female presented with swelling in left arm 
for last 6 months with swelling of size of 5*4 cm in 
left arm which has gradually increased in size. She 
also complained of pain in left arm radiating along 
medial aspect of forearm up to left hand. The pain 
was sharp, and more during night. She also 
complained of tingling sensation in left upper limb, 
palm, index and thumb and had history of dropping 
objects from left hand. On examination, there was 
decreased sensation along radial three digits with no 
neurovascular deficit. 
The patient was evaluated with Magnetic 
resonance imaging (Figure 1) which revealed a well 
encapsulated oval lesion in left upper arm medially 
burrowing in left biceps and coracobrachialis muscle. 
The lesion minimally indented the left brachial 
artery. The lesion was in continuity with median 
nerve which showed mild enhancement in early and 
late arterial phase with heterogenous enhancement 
with non enhancing / cystic areas in venous and 
delayed phase. Overall findings were in favour of 
neurogenic tumor. 
 
 
 
Electrodiagnostic studies and nerve conduction 
studies of median nerve were within normal limits. 
Ultrasound color Doppler peripheral venous single 
upper limb was suggestive of hetero-echoic lesion 
with internal cystic components measuring 43*23 
mm causing compression of underlying axillary 
artery medially at its lower margin. The patient was 
taken up for surgical resection with preservation of 
nerve fascicles. The mass found to be associated 
intimately associated with nerve, soft in consistency 
and moderately vascular in nature. Microvsacular 
excision of mass was done with preservation of 
nerve fascicles (Figure 2). 
On histopathological analysis, tumor was greyish 
tan made up of spindle cells with sheets of cells with 
vesicular nuclei and ill-defined cell margins 
suggestive of mild epitheloid morphology (Figure 3). 
Focal areas showed perivascular arrangement with 
cells separated by blood vessels with occasional 
mitosis and areas of hemorrhage. Collagen and 
osseous tissue was seen adjacent to tumor. On 
immunohistochemistry CD 99 was positive, CK 
negative, Synaptophysin negative, S-100 negative, 
HMB-45 negative, BCL2 positive and Ki-67 was 15-20 
% in cellular areas (Figure 4). The histopathological 
and immunohistochemical analysis were in favour of 
synovial sarcoma. Post operatively, whole body 
PET/CECT scan was done for any metastasis and 
restaging. This was suggestive of small minimally 
metabolic active solid soft tissue thickening in 
proximal left biceps muscle indenting left brachial 
artery probably? residual lesion. Post excision, 
patient received radiotherapy. 
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DISCUSSION 
Synovial sarcomas arising from median nerve are 
very rare and rarest tumors published in literature. 
Other sarcomas arising from various nerves 
reported in literature are from radial, common 
digital, posterior tibialis, peroneal, facial nerve, S1 
root, C7 root and brachial plexus. There are three 
basic histology features of synovial sarcoma. The 
most common pattern is biphasic followed by 
monophasic and poorly differentiated synovial 
sarcomas. Synovial sarcoma with biphasic type 
consisted of epithelial cells with fibroblast like 
spindle cell in various proportions. Monophasic type 
consists of spindle cells only and are difficult to 
differentiate from other soft tissue and nerve tumors 
but now can be differentiated on the basis of 
immunohistochemical analysis4. Third pattern of 
poorly differentiated synovial sarcomas that has 
worse prognosis and has also been described6. 
Prognosis of biphasic versus monophasic is still 
under debate9,10,11,12. 
 
The present case in our study was biphasic synovial 
sarcoma having both epithelial and spindle cells in 
various proportions. It was immunohistochemical 
positive for CD99 and bcl2. The neoplastic 
proliferation with characteristic SS18-SSX1 with 
chromosomal fusion at molecular level is a feature 
consistent with diagnosis with synovial sarcoma4. 
Patient was advised for chromosomal analysis, but 
due to financial constraints patient refused for same. 
Published cases of median nerve synovial sarcoma 
with review of literature is summarised in table 1 and 
table 2 respectively. 
Chromosomal translocation is the most efficient 
way to establish the diagnosis of synovial sarcoma. A 
gene translocation between chromosomes 18 and X 
t(x;18) (p11.2; q11.2) occurs in over 90% of synovial 
sarcomas4. This leads to fusion of one of two variants 
of the SSX gene with the SYT gene, resulting in either 
the SYT/SSX1 or SYT/SSX2 chimeric fusion proteins4,6. 
Nearly all biphasic tumors express SYT/SSX1, while 
monophasic tumors express SYT/SSX1 in 
approximately half of the cases and SYT/SSX2 in the 
remainder13. Patients with SYT/SSX2 expressing 
tumors have a significantly better prognosis when 
compared to those with SYT/SSX1 tumors in terms of 
rates of metastasis and overall survival13,14,15,16. 
 Factors associated with poor prognosis includes old 
age, tumor size more than 5 cm, bone, nerve and 
vascular invasion and poor differentiation with 
higher mitotic index 12,17,18,19.Management of synovial 
sarcoma is wide surgical excision, radiation therapy, 
and adjuvant chemotherapy which has been found 
to be correlated to be associated with better 
prognosis2,20 
Surgical management followed by radiation and 
chemotherapy is associated with good prognosis2,20. 
5-year survival rates of synovial sarcomas have been 
around 50-60%, inspite of advances in 
treatment2,21,22. Mortality in synovial sarcoma results 
from distant metastasis, most frequently to lung23. 
Radical surgical incision followed by radiation 
allowed for potential decrease in local recurrence 
but systemic metastasis remained high even with 
adjunct chemotherapy24. 
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CONCLUSION 
Synovial sarcoma involving median nerve is a rare 
and aggressive tumor and is one of the few cases 
already published in literature. Synovial sarcoma can 
occur anywhere in our body and should be kept in 
differentials involving peripheral nerves as in our 
case. As diagnosis is always made post-operative on 
histo-patholoical analysis with immuno-
histochemistry, resulting in change in treatment 
strategy and final outcome of patient. As in our 
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patient, preoperative diagnosis was a benign 
neurofibroma/schwannoma, we must be aware of 
aggressive tumor which overall changes the 
complete treatment and should be always be kept in 
differentials and managed accordingly. 
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